A 90-day dietary study on kappa carrageenan with emphasis on the gastrointestinal tract

Food and Chemical Toxicology

Volumn 45, Issue 1, 2007, Pages 98-106

  Weiner, Myra L ^a   Nuber, David ^a   Blakemore, William R ^a   Harriman, Jay F ^b   Cohen, Samuel M ^c  

^a FMC CORPORATION   (United States)

^b WIL RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Carrageenan; Colon roll; Kappa carrageenan; Molecular weight; Subchronic toxicity

Indexed keywords

CARRAGEENAN; EOSIN; FOOD ADDITIVE; HEMATOXYLIN; PARAFFIN;

ADRENAL GLAND; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY WEIGHT; BRAIN WEIGHT; CLINICAL EXAMINATION; COLON; CONTROLLED STUDY; DRUG MEGADOSE; FECES ANALYSIS; FEMALE; FOOD INTAKE; GASTROINTESTINAL TOXICITY; GASTROINTESTINAL TRACT; GOOD LABORATORY PRACTICE; HEART WEIGHT; HEMATOLOGY; HISTOPATHOLOGY; KIDNEY MASS; LIVER WEIGHT; LOW DRUG DOSE; MALE; MOLECULAR WEIGHT; NONHUMAN; OPHTHALMOLOGY; ORGAN WEIGHT; OVARY; PARATHYROID GLAND; RAT; SPLEEN WEIGHT; STAINING; TESTIS WEIGHT; THYROID WEIGHT; URINALYSIS;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CARRAGEENAN; CLINICAL CHEMISTRY TESTS; DIARRHEA; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; EUROPEAN UNION; FEMALE; FOOD ADDITIVES; GASTROINTESTINAL TRACT; HEMATOLOGIC TESTS; HISTOLOGICAL TECHNIQUES; MALE; MOLECULAR WEIGHT; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RATS; RATS, INBRED F344;

EID: 33751204748     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.07.033     Document Type: Article

References (28)

1. Bird R.P., and Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 112-113 (2000) 395-402
2. Boivin G.P., Washington K., Yang K., Ward J.M., Pretlow T.P., Russell R., Besselsen D.G., Godfrey V.L., Doetschman T., Dove W.F., Pitot H.C., Halberg R.B., Itzkowitz S.H., Groden J., and Coffey R.J. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroetnerology 2003 (2003) 762-777
3. Cohen S.M., and Ito N. A critical review of the toxicological effects of carrageenan and processed eucheuma seaweed on the gastrointestinal tract. Crit. Rev. Toxicol. 32 (2002) 413-444
4. Commission Directive, 2004/45/EC of 16 April 2004 amending Directive 96/77/EC laying down specific purity criteria on food additives other than colours and sweetners. Official Journal of European Union, 20 April 2004, L113/19-L113/21.
5. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics 20 (1964) 482-491
6. European Commission, 2003. Health & Consumer Protection Directorate-General, Opinion of the Scientific Committee on Food on Carrageenan, SCF/CS/ADD/EMU/199 Final, 5 March 2003. http://europa.eu.int/comm/food/fs/sc/scf.
7. Frantz J.D., Betton G., Cartwright M.E., Crissman J.W., Macklin A.W., and Maronpot R.R. Proliferative lesions of the non-glandular and glandular stomach in rats, GI-3. Guides for Toxicologic Pathology (1991), STP/ARP/AFIP, Washington, DC
8. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. World Health Organization 31 (1983) 79-94
9. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. World Health Organization Suppl. 7 (1987) 48
10. JECFA, 2002. Safety evaluation of certain food additives and contaminants. Prepared by the Fifty-seventh meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA). Carrageenan and Processed Eucheuma Seaweed (addendum). WHO Food Additives Series 48, pp. 91-101. http://www.inchem.org/documents/jecfa/jecmono/v48je08.htm.
11. Marinalg International website, 2006. www.Marinalg.org.
12. Moolenbeek C., and Ruitenberg E.J. The "Swiss roll": a simple technique for histological studies of the rodent intestine. Lab. Anim. 15 (1981) 57-59
13. Oohashi Y., Ishioka T.T., Wakabayashi K., and Kuwabara N. A study of carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum. Cancer Lett. 14 (1981) 267-272
14. Organization for Economic Co-operation and Development (OECD), 1998a. OECD Principles on good laboratory practice (as revised in 1997). Series on Principles of Good Laboratory Practice and Compliance Monitoring-Number 1. OECD ENV/MC/CHEM (98)17, Environment Directorate, OECD Paris, France.
15. Organization for Economic Co-operation and Development (OECD). OECD guidelines for the testing of chemicals (1998), OECD Publishers, Paris, France
16. Pitot H.C., Hikita H., Dragan Y., Sargent L., and Haas M. Review article: the stages of gastrointestinal carcinogenesis - application of rodent models to human disease. Aliment. Pharmacol. Ther. 14 Suppl. 1 (2000) 153-160
17. Snedecor G.W., and Cochran W.G. One way classifications; analysis of variance. Statistical Methods. 7th ed. (1980), The Iowa State University Press, Ames, IA 215-237
18. Tobacman J.K. Filament disassembly and loss of mammary myoepithelial cells after exposure to (lambda) carrageenan. Cancer Res. 37 (1997) 2823-2826
19. Tobacman J.K. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ. Health Perspect. 109 (2001) 983-994
20. Tobacman J.K., Wallace R.B., and Zimmerman M.B. Consumption of carrageenan and water soluble polymers used as food additives and incidence of mammary carcinoma. Med. Hypothesis 56 5 (2001) 589-598
21. Uno Y., Omoto T., Goto Y., Asai I., Nakamura M., and Maitani T. Molecular weight distribution of carrageenans studied by a combined gel permeation/inductively coupled plasma (GPC/ICP) method. Food Addit. Contam. 18 (2001) 763-772
22. US Environmental Protection Agency (US EPA), 1989. Toxic Substances Control Act (TSCA), Good laboratory practice standards; final rule. 40 CFR Part 792, Washington, DC.
23. US Food and Drug Administration (US FDA) Bureau of Foods, 1982. Toxicological principles for the safety assessment of direct food additives and color additives used in food, US Department of Commerce, Washington, DC, NTIS PB83-170696.
24. US United States Food and Drug Administration (US FDA), 1987. Good laboratory practice regulations; final rule. 21 CFR Part 58, Washington, DC.
25. Wakabayaski K., Inagaki T., Fujimoto Y., and Fukuda Y. Induction by degraded carrageenan of colorectal tumors in rats. Cancer Lett. 4 (1978) 171-176
26. Weiner M.L. Intestinal transport of some macromolecules in food. Food Chem. Toxicol. 26 (1988) 867-880
27. Weiner M.L. Toxicological properties of carrageenan. Agents Act. 32 (1991) 46-51
28. Whiteley L.O., Anver M.R., Bottis S., and Jokinen P. Proliferative lesions of the intestine, salivary glands, oral cavity, and esophagus in rats, GI-1/2/4. Guides for Toxicology Pathology (1996), STP/ARP/FIP, Washington, DC